{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:36:16Z","timestamp":1791873376026,"version":"4.3.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T00:00:00Z","timestamp":1740873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T00:00:00Z","timestamp":1740873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Bile acid overload critically drives the pathogenesis of cholestatic liver injury (CLI). While ceramide metabolism has garnered increasing interest in liver research, the role of ceramides in CLI remains unclear. This study investigates the function of alkaline ceramidase 3 (ACER3)-catalyzed hydrolysis of unsaturated ceramides in CLI. Using clinical specimens, this work finds that <jats:italic>ACER3<\/jats:italic> expression is upregulated in the cholestatic liver and positively correlated with the severity of CLI in patients. <jats:italic>Acer3<\/jats:italic> ablation increases ceramide(d18:1\/18:1) and attenuates bile duct ligation-induced CLI in female mice with reduced hepatic necrosis, inflammation, and fibrosis. However, it does not significantly impact CLI in male mice. Moreover, ceramide(d18:1\/18:1) treatment attenuates CLI in wild-type female mice. Similarly, <jats:italic>ACER3<\/jats:italic> knockdown and ceramide(d18:1\/18:1) treatment prevent lithocholic-acid-induced cell death in human-liver-derived HepG2 cells. Mechanistically, ceramide(d18:1\/18:1) binds the ligand binding domain of the liver X receptor \u03b2, acting as an agonist to activate its transcriptional functions. This activation upregulates sulfotransferase 2A1-catalyzed bile acid sulfation, normalizes bile acid metabolism, and restores lipogenesis, thereby reducing bile acid overload in hepatocytes to attenuate CLI. Our findings uncover the role of ceramide(d18:1\/18:1)-liver X receptor \u03b2 signaling in mitigating bile acid overload in the cholestatic liver, offering mechanistic insights and suggesting therapeutic potential for targeting ACER3 and ceramide(d18:1\/18:1) for CLI.<\/jats:p>","DOI":"10.1038\/s41467-025-57330-7","type":"journal-article","created":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T15:59:56Z","timestamp":1740931196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Targeting the ceramidase ACER3 attenuates cholestasis in mice by mitigating bile acid overload via unsaturated ceramide-mediated LXR\u03b2 signaling transduction"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3523-9166","authenticated-orcid":false,"given":"Leyi","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cungui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingying","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7147-1243","authenticated-orcid":false,"given":"Qingping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3583-2881","authenticated-orcid":false,"given":"Chuanjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5814-817X","authenticated-orcid":false,"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,2]]},"reference":[{"key":"57330_CR1","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s40265-021-01545-7","volume":"81","author":"S Hasegawa","year":"2021","unstructured":"Hasegawa, S. et al. Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents. Drugs 81, 1181\u20131192 (2021).","journal-title":"Drugs"},{"key":"57330_CR2","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/hep.28965","volume":"65","author":"PLM Jansen","year":"2017","unstructured":"Jansen, P. L. M. et al. The ascending pathophysiology of cholestatic liver disease. Hepatology 65, 722\u2013738 (2017).","journal-title":"Hepatology"},{"key":"57330_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jhep.2017.04.026","volume":"67","author":"P Fickert","year":"2017","unstructured":"Fickert, P. & Wagner, M. Biliary bile acids in hepatobiliary injury - What is the link? J. Hepatol. 67, 619\u2013631 (2017).","journal-title":"J. Hepatol."},{"key":"57330_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","volume":"19","author":"CD Fuchs","year":"2022","unstructured":"Fuchs, C. D. & Trauner, M. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nat. Rev. Gastroenterol. Hepatol. 19, 432\u2013450 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"57330_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","volume":"9","author":"JS Fleishman","year":"2024","unstructured":"Fleishman, J. S. & Kumar, S. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduct. Target. Ther. 9, 97 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"57330_CR6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/hep.24148","volume":"53","author":"M Wagner","year":"2011","unstructured":"Wagner, M., Zollner, G. & Trauner, M. Nuclear receptors in liver disease. Hepatology 53, 1023\u20131034 (2011).","journal-title":"Hepatology"},{"key":"57330_CR7","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1124\/pharmrev.121.000436","volume":"75","author":"TP Burris","year":"2023","unstructured":"Burris, T. P. et al. International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily\u2014Update 2023. Pharmacol. Rev. 75, 1233\u20131318 (2023).","journal-title":"Pharmacol. Rev."},{"key":"57330_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cmet.2006.11.012","volume":"5","author":"W Chen","year":"2007","unstructured":"Chen, W., Chen, G., Head, D. L., Mangelsdorf, D. J. & Russell, D. W. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab. 5, 73\u201379 (2007).","journal-title":"Cell Metab."},{"key":"57330_CR9","doi-asserted-by":"publisher","first-page":"105533","DOI":"10.1016\/j.tiv.2022.105533","volume":"87","author":"V Kastrinou Lampou","year":"2023","unstructured":"Kastrinou Lampou, V. et al. Novel insights into bile acid detoxification via CYP, UGT and SULT enzymes. Toxicol. Vitr. 87, 105533 (2023).","journal-title":"Toxicol. Vitr."},{"key":"57330_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/toxsci\/kfn268","volume":"108","author":"Y Alnouti","year":"2009","unstructured":"Alnouti, Y. Bile Acid sulfation: a pathway of bile acid elimination and detoxification. Toxicol. Sci. 108, 225\u2013246 (2009).","journal-title":"Toxicol. Sci."},{"key":"57330_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/hep.23265","volume":"51","author":"CJ Soroka","year":"2010","unstructured":"Soroka, C. J., Mennone, A., Hagey, L. R., Ballatori, N. & Boyer, J. L. Mouse organic solute transporter \u03b1 deficiency enhances renal excretion of bile acids and attenuates cholestasis. Hepatology 51, 181\u2013190 (2010).","journal-title":"Hepatology"},{"key":"57330_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm3312","volume":"13","author":"AC Calkin","year":"2012","unstructured":"Calkin, A. C. & Tontonoz, P. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat. Rev. Mol. Cell Biol. 13, 213\u2013224 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"57330_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jhep.2009.05.012","volume":"51","author":"M Wagner","year":"2009","unstructured":"Wagner, M., Zollner, G. & Trauner, M. New molecular insights into the mechanisms of cholestasis. J. Hepatol. 51, 565\u2013580 (2009).","journal-title":"J. Hepatol."},{"key":"57330_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun, Y. A. & Obeid, L. M. Sphingolipids and their metabolism in physiology and disease. Nat. Rev. Mol. Cell Biol. 19, 175\u2013191 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"57330_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jpba.2019.04.009","volume":"171","author":"S Lin","year":"2019","unstructured":"Lin, S. et al. A systemic combined nontargeted and targeted LC-MS based metabolomic strategy of plasma and liver on pathology exploration of alpha-naphthylisothiocyanate induced cholestatic liver injury in mice. J. Pharm. Biomed. Anal. 171, 180\u2013192 (2019).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"57330_CR16","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/hep.24193","volume":"53","author":"T Matsubara","year":"2011","unstructured":"Matsubara, T. et al. Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice. Hepatology 53, 1282\u20131293 (2011).","journal-title":"Hepatology"},{"key":"57330_CR17","doi-asserted-by":"publisher","first-page":"106399","DOI":"10.1016\/j.prostaglandins.2019.106399","volume":"147","author":"A Mikucka-Niczyporuk","year":"2020","unstructured":"Mikucka-Niczyporuk, A. et al. Role of sphingolipids in the pathogenesis of intrahepatic cholestasis. Prostaglandins Other Lipid Mediat. 147, 106399 (2020).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"57330_CR18","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1126\/science.8456305","volume":"259","author":"LM Obeid","year":"1993","unstructured":"Obeid, L. M., Linardic, C. M., Karolak, L. A. & Hannun, Y. A. Programmed Cell Death Induced by Ceramide. Sci. (Am. Assoc. Advancement Sci.) 259, 1769\u20131771 (1993).","journal-title":"Sci. (Am. Assoc. Advancement Sci.)"},{"key":"57330_CR19","doi-asserted-by":"crossref","unstructured":"Yang, L. et al. Sphingosine 1-Phosphate Receptor 2 and 3 Mediate Bone Marrow-Derived Monocyte\/Macrophage Motility in Cholestatic Liver Injury in Mice. Sci Rep. 5 (2015).","DOI":"10.1038\/srep13423"},{"key":"57330_CR20","doi-asserted-by":"crossref","unstructured":"Wu, Q. et al. Suppressing the intestinal farnesoid X receptor\/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis. J. Clin. Invest. 131 (2021).","DOI":"10.1172\/JCI142865"},{"key":"57330_CR21","doi-asserted-by":"publisher","first-page":"109860","DOI":"10.1016\/j.cellsig.2020.109860","volume":"78","author":"R Xu","year":"2021","unstructured":"Xu, R., Antwi, B. P. & Mao, C. Alkaline ceramidase family: The first two decades. Cell. Signal. 78, 109860 (2021).","journal-title":"Cell. Signal."},{"key":"57330_CR22","doi-asserted-by":"publisher","first-page":"8995","DOI":"10.1074\/jbc.M109.063586","volume":"285","author":"W Hu","year":"2010","unstructured":"Hu, W., Ruijuan, X. W. S. Z., Jacek, B. & Lina, M. O. A. C. Alkaline Ceramidase 3 (ACER3) Hydrolyzes Unsaturated Long-chain Ceramides, and Its Down-regulation Inhibits Both Cell Proliferation and Apoptosis. J. Biol. Chem. 285, 8995\u20139007 (2010).","journal-title":"J. Biol. Chem."},{"key":"57330_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005591","volume":"11","author":"K Wang","year":"2015","unstructured":"Wang, K. et al. Alkaline Ceramidase 3 Deficiency Results in Purkinje Cell Degeneration and Cerebellar Ataxia Due to Dyshomeostasis of Sphingolipids in the Brain. Plos Genet. 11, e1005591 (2015).","journal-title":"Plos Genet."},{"key":"57330_CR24","doi-asserted-by":"crossref","unstructured":"Wang, K. et al. Targeting alkaline ceramidase 3 alleviates the severity of nonalcoholic steatohepatitis by reducing oxidative stress. Cell Death Dis. 11 (2020).","DOI":"10.1038\/s41419-020-2396-1"},{"key":"57330_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2020.07.004","volume":"159","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. Generation of sphingosine-1-phosphate by sphingosine kinase 1 protects nonalcoholic fatty liver from ischemia\/reperfusion injury through alleviating reactive oxygen species production in hepatocytes. Free Radic. Biol. Med. 159, 136\u2013149 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"57330_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03616-9","volume":"12","author":"H Sun","year":"2021","unstructured":"Sun, H. et al. Ceramides and sphingosine-1-phosphate mediate the distinct effects of M1\/M2-macrophage infusion on liver recovery after hepatectomy. Cell Death Dis. 12, 324 (2021).","journal-title":"Cell Death Dis."},{"key":"57330_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.21037\/hbsn-21-133","volume":"12","author":"S Yu","year":"2023","unstructured":"Yu, S. et al. Nonalcoholic steatohepatitis critically rewires the ischemia\/reperfusion-induced dysregulation of cardiolipins and sphingolipids in mice. Hepatobil. Surg. Nutr. 12, 3\u201319 (2023).","journal-title":"Hepatobil. Surg. Nutr."},{"key":"57330_CR28","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1053\/j.gastro.2018.07.031","volume":"155","author":"Q Pan","year":"2018","unstructured":"Pan, Q. et al. Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in Cholestasis. Gastroenterology 155, 1578\u20131592 (2018).","journal-title":"Gastroenterology"},{"key":"57330_CR29","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jhep.2021.02.035","volume":"75","author":"J Li","year":"2021","unstructured":"Li, J. et al. Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism. J. Hepatol. 75, 400\u2013413 (2021).","journal-title":"J. Hepatol."},{"key":"57330_CR30","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jhep.2014.10.033","volume":"62","author":"Y Xiao","year":"2015","unstructured":"Xiao, Y. et al. Dysregulated miR-124 and miR-200 expression contribute to cholangiocyte proliferation in the cholestatic liver by targeting IL-6\/STAT3 signalling. J. Hepatol. 62, 889\u2013896 (2015).","journal-title":"J. Hepatol."},{"key":"57330_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cbi.2016.05.005","volume":"259","author":"M Coughtrie","year":"2016","unstructured":"Coughtrie, M. Function and organization of the human cytosolic sulfotransferase (SULT) family. Chem. -Biol. Interact. 259, 2\u20137 (2016).","journal-title":"Chem. -Biol. Interact."},{"key":"57330_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3109\/03602532.2012.748794","volume":"45","author":"M Runge-Morris","year":"2013","unstructured":"Runge-Morris, M., Kocarek, T. A. & Falany, C. N. Regulation of the cytosolic sulfotransferases by nuclear receptors. Drug Metab. Rev. 45, 15\u201333 (2013).","journal-title":"Drug Metab. Rev."},{"key":"57330_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","volume":"14","author":"B Wang","year":"2018","unstructured":"Wang, B. & Tontonoz, P. Liver X receptors in lipid signalling and membrane homeostasis. Nat. Rev. Endocrinol. 14, 452\u2013463 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"57330_CR34","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.biotechadv.2018.03.003","volume":"36","author":"V Hiebl","year":"2018","unstructured":"Hiebl, V., Ladurner, A., Latkolik, S. & Dirsch, V. M. Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR. Biotechnol. Adv. 36, 1657\u20131698 (2018).","journal-title":"Biotechnol. Adv."},{"key":"57330_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nsmb.2778","volume":"21","author":"X Lou","year":"2014","unstructured":"Lou, X. et al. Structure of the retinoid X receptor \u03b1\u2013liver X receptor \u03b2 (RXR\u03b1\u2013LXR\u03b2) heterodimer on DNA. Nat. Struct. Mol. Biol. 21, 277\u2013281 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"57330_CR36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hep.21494","volume":"45","author":"H Uppal","year":"2007","unstructured":"Uppal, H. et al. Activation of LXRs prevents bile acid toxicity and cholestasis in female mice. Hepatology 45, 422\u2013432 (2007).","journal-title":"Hepatology"},{"key":"57330_CR37","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1053\/j.gastro.2018.04.032","volume":"155","author":"T Liu","year":"2018","unstructured":"Liu, T. et al. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer. Gastroenterology 155, 557\u2013571 (2018).","journal-title":"Gastroenterology"},{"key":"57330_CR38","doi-asserted-by":"publisher","first-page":"946","DOI":"10.2174\/1389200211314090002","volume":"14","author":"MT Donato","year":"2013","unstructured":"Donato, M. T., Jover, R. & G\u00f3mez-Lech\u00f3n, M. J. Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering. Curr. Drug Metab. 14, 946 (2013).","journal-title":"Curr. Drug Metab."},{"key":"57330_CR39","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.tiv.2017.07.024","volume":"44","author":"WFPM Van den Hof","year":"2017","unstructured":"Van den Hof, W. F. P. M. et al. Validation of gene expression profiles from cholestatic hepatotoxicants in vitro against human in vivo cholestasis. Toxicol. Vitr. 44, 322\u2013329 (2017).","journal-title":"Toxicol. Vitr."},{"key":"57330_CR40","doi-asserted-by":"crossref","unstructured":"Komati, R. et al. Ligands of Therapeutic Utility for the Liver X Receptors. Molecules. 22 (2017).","DOI":"10.3390\/molecules22010088"},{"key":"57330_CR41","doi-asserted-by":"publisher","first-page":"27138","DOI":"10.1074\/jbc.M302260200","volume":"278","author":"S Williams","year":"2003","unstructured":"Williams, S. et al. X-ray Crystal Structure of the Liver X Receptor \u03b2 Ligand Binding Domain. J. Biol. Chem. 278, 27138\u201327143 (2003).","journal-title":"J. Biol. Chem."},{"key":"57330_CR42","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1021\/acs.jmedchem.5b02029","volume":"59","author":"Y Zheng","year":"2016","unstructured":"Zheng, Y. et al. Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) \u03b2 Agonist. J. Med. Chem. 59, 3264\u20133271 (2016).","journal-title":"J. Med. Chem."},{"key":"57330_CR43","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.1158\/0008-5472.CAN-03-1476","volume":"64","author":"Y Uchida","year":"2004","unstructured":"Uchida, Y. et al. Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60\/ADR cells. Cancer Res. 64, 6271\u20136279 (2004).","journal-title":"Cancer Res."},{"key":"57330_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.268","volume":"6","author":"AA Shamseddine","year":"2015","unstructured":"Shamseddine, A. A. et al. P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest. Cell Death Dis. 6, e1947 (2015).","journal-title":"Cell Death Dis."},{"key":"57330_CR45","doi-asserted-by":"publisher","first-page":"151967","DOI":"10.1016\/j.scitotenv.2021.151967","volume":"815","author":"P Simeckova","year":"2022","unstructured":"Simeckova, P. et al. In vitro profiling of toxic effects of environmental polycyclic aromatic hydrocarbons on nuclear receptor signaling, disruption of endogenous metabolism and induction of cellular stress. Sci. Total Environ. 815, 151967 (2022).","journal-title":"Sci. Total Environ."},{"key":"57330_CR46","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1158\/1535-7163.MCT-17-0485","volume":"16","author":"L Dai","year":"2017","unstructured":"Dai, L. et al. ABC294640, A Novel Sphingosine Kinase 2 Inhibitor, Induces Oncogenic Virus-Infected Cell Autophagic Death and Represses Tumor Growth. Mol. Cancer Ther. 16, 2724\u20132734 (2017).","journal-title":"Mol. Cancer Ther."},{"key":"57330_CR47","doi-asserted-by":"publisher","first-page":"eabl7895","DOI":"10.1126\/scitranslmed.abl7895","volume":"15","author":"L Su","year":"2023","unstructured":"Su, L. et al. Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models. Sci. Transl. Med. 15, eabl7895 (2023).","journal-title":"Sci. Transl. Med."},{"key":"57330_CR48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/j.gastro.2011.09.051","volume":"142","author":"T Moustafa","year":"2012","unstructured":"Moustafa, T. et al. Alterations in Lipid Metabolism Mediate Inflammation, Fibrosis, and Proliferation in a Mouse Model of Chronic Cholestatic Liver Injury. Gastroenterology 142, 140\u2013151 (2012).","journal-title":"Gastroenterology"},{"key":"57330_CR49","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1038\/s41374-020-0457-9","volume":"100","author":"K Irungbam","year":"2020","unstructured":"Irungbam, K. et al. Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic mice. Lab. Invest. 100, 1411\u20131424 (2020).","journal-title":"Lab. Invest."},{"key":"57330_CR50","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s42003-019-0675-0","volume":"2","author":"AY Belorusova","year":"2019","unstructured":"Belorusova, A. Y. et al. Structural analysis identifies an escape route from the adverse lipogenic effects of liver X receptor ligands. Commun. Biol. 2, 431 (2019).","journal-title":"Commun. Biol."},{"key":"57330_CR51","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1210\/me.2008-0295","volume":"23","author":"KH Kim","year":"2009","unstructured":"Kim, K. H. et al. Liver X receptor ligands suppress ubiquitination and degradation of LXRalpha by displacing BARD1\/BRCA1. Mol. Endocrinol. 23, 466\u2013474 (2009).","journal-title":"Mol. Endocrinol."},{"key":"57330_CR52","doi-asserted-by":"publisher","first-page":"43509","DOI":"10.1074\/jbc.M106155200","volume":"276","author":"KD Whitney","year":"2001","unstructured":"Whitney, K. D. et al. Liver X receptor (LXR) regulation of the LXRalpha gene in human macrophages. J. Biol. Chem. 276, 43509\u201343515 (2001).","journal-title":"J. Biol. Chem."},{"key":"57330_CR53","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1194\/jlr.M400119-JLR200","volume":"45","author":"SM Ulven","year":"2004","unstructured":"Ulven, S. M., Dalen, K. T., Gustafsson, J. A. & Nebb, H. I. Tissue-specific autoregulation of the LXRalpha gene facilitates induction of apoE in mouse adipose tissue. J. Lipid Res. 45, 2052\u20132062 (2004).","journal-title":"J. Lipid Res."},{"key":"57330_CR54","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/toxsci\/kfl050","volume":"93","author":"Y Alnouti","year":"2006","unstructured":"Alnouti, Y. & Klaassen, C. D. Tissue Distribution and Ontogeny of Sulfotransferase Enzymes in Mice. Toxicol. Sci. 93, 242\u2013255 (2006).","journal-title":"Toxicol. Sci."},{"key":"57330_CR55","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1021\/acs.molpharmaceut.7b00435","volume":"14","author":"J Chen","year":"2017","unstructured":"Chen, J. et al. Profiles and Gender-Specifics of UDP-Glucuronosyltransferases and Sulfotransferases Expressions in the Major Metabolic Organs of Wild-Type and Efflux Transporter Knockout FVB Mice. Mol. Pharm. 14, 2967\u20132976 (2017).","journal-title":"Mol. Pharm."},{"key":"57330_CR56","first-page":"2887","volume":"60","author":"W Davis","year":"2000","unstructured":"Davis, W. et al. Sex differences in the activation of tamoxifen to DNA binding species in rat liver in vivo and in rat hepatocytes in vitro: role of sulfotransferase induction. Cancer Res. 60, 2887\u20132891 (2000).","journal-title":"Cancer Res."},{"key":"57330_CR57","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.bcp.2008.07.032","volume":"76","author":"TA Kocarek","year":"2008","unstructured":"Kocarek, T. A., Duanmu, Z., Fang, H. L. & Runge-Morris, M. Age- and sex-dependent expression of multiple murine hepatic hydroxysteroid sulfotransferase (SULT2A) genes. Biochem. Pharmacol. 76, 1036\u20131046 (2008).","journal-title":"Biochem. Pharmacol."},{"key":"57330_CR58","doi-asserted-by":"crossref","unstructured":"Okuda, H., Nojima, H., Watanabe, N. & Watabe, T. Sulphotransferase-mediated activation of the carcinogen 5-hydroxymethyl-chrysene. Species and sex differences in tissue distribution of the enzyme activity and a possible participation of hydroxysteroid sulphotransferases. Biochem. Pharmacol., (1989).","DOI":"10.1016\/0006-2952(89)90008-7"},{"key":"57330_CR59","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1042\/bj2890233","volume":"289","author":"KA Comer","year":"1993","unstructured":"Comer, K. A., Falany, J. L. & Falany, C. N. Cloning and expression of human liver dehydroepiandrosterone sulphotransferase. Biochem. J. 289, 233\u2013240 (1993).","journal-title":"Biochem. J."},{"key":"57330_CR60","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.bcp.2015.02.010","volume":"94","author":"X Tian","year":"2015","unstructured":"Tian, X. et al. Sulfation of melatonin: enzymatic characterization, differences of organs, species and genders, and bioactivity variation. Biochem. Pharmacol. 94, 282\u2013296 (2015).","journal-title":"Biochem. Pharmacol."},{"key":"57330_CR61","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1038\/s41388-021-01987-z","volume":"40","author":"W Guo","year":"2021","unstructured":"Guo, W. et al. M6A methylation of DEGS2, a key ceramide-synthesizing enzyme, is involved in colorectal cancer progression through ceramide synthesis. Oncogene 40, 5913\u20135924 (2021).","journal-title":"Oncogene"},{"key":"57330_CR62","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1432-1033.1994.tb18844.x","volume":"222","author":"A Zschoche","year":"1994","unstructured":"Zschoche, A., Furst, W., Schwarzmann, G. & Sanhoff, K. Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis. Eur. J. Biochem. 222, 83\u201390 (1994).","journal-title":"Eur. J. Biochem."},{"key":"57330_CR63","doi-asserted-by":"crossref","unstructured":"Dei, C. M. et al. Convenient and Sensitive Measurement of Lactosylceramide Synthase Activity Using Deuterated Glucosylceramide and Mass Spectrometry. Int. J. Mol. Sci. 24 (2023).","DOI":"10.3390\/ijms24065291"},{"key":"57330_CR64","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3681","volume":"20","author":"L Mayo","year":"2014","unstructured":"Mayo, L. et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat. Med. 20, 1147\u20131156 (2014).","journal-title":"Nat. Med."},{"key":"57330_CR65","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1172\/JCI76738","volume":"125","author":"C Jiang","year":"2015","unstructured":"Jiang, C. et al. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. J. Clin. Invest. 125, 386\u2013402 (2015).","journal-title":"J. Clin. Invest."},{"key":"57330_CR66","doi-asserted-by":"crossref","unstructured":"Tag, C. G. et al. Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis. J. Vis. Exp., (2015).","DOI":"10.3791\/52438"},{"key":"57330_CR67","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","volume":"14","author":"F Wang","year":"2012","unstructured":"Wang, F. et al. RNAscope. J. Mol. Diagnost. 14, 22\u201329 (2012).","journal-title":"J. Mol. Diagnost."},{"key":"57330_CR68","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.jpba.2011.03.035","volume":"55","author":"J Huang","year":"2011","unstructured":"Huang, J., Bathena, S. P. R., Csanaky, I. L. & Alnouti, Y. Simultaneous characterization of bile acids and their sulfate metabolites in mouse liver, plasma, bile, and urine using LC\u2013MS\/MS. J. Pharm. Biomed. Anal. 55, 1111\u20131119 (2011).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"57330_CR69","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1021\/acs.jproteome.5b00676","volume":"14","author":"K Zhou","year":"2015","unstructured":"Zhou, K. et al. Distinct Plasma Bile Acid Profiles of Biliary Atresia and Neonatal Hepatitis Syndrome. J. Proteome Res. 14, 4844\u20134850 (2015).","journal-title":"J. Proteome Res."},{"key":"57330_CR70","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","volume":"49","author":"V Matyash","year":"2008","unstructured":"Matyash, V., Liebisch, G., Kurzchalia, T. V., Shevchenko, A. & Schwudke, D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 49, 1137\u20131146 (2008).","journal-title":"J. Lipid Res."},{"key":"57330_CR71","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1021\/ac5009964","volume":"86","author":"JR Wang","year":"2014","unstructured":"Wang, J. R. et al. Improved sphingolipidomic approach based on ultra-high performance liquid chromatography and multiple mass spectrometries with application to cellular neurotoxicity. Anal. Chem. 86, 5688\u20135696 (2014).","journal-title":"Anal. Chem."},{"key":"57330_CR72","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s42255-021-00425-4","volume":"3","author":"SM Lam","year":"2021","unstructured":"Lam, S. M. et al. A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19. Nat. Metab. 3, 909\u2013922 (2021).","journal-title":"Nat. Metab."},{"key":"57330_CR73","doi-asserted-by":"publisher","first-page":"W478","DOI":"10.1093\/nar\/gku377","volume":"42","author":"CC Huang","year":"2014","unstructured":"Huang, C. C., Meng, E. C., Morris, J. H., Pettersen, E. F. & Ferrin, T. E. Enhancing UCSF Chimera through web services. Nucleic Acids Res. 42, W478\u2013W484 (2014).","journal-title":"Nucleic Acids Res."},{"key":"57330_CR74","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/jcc.23905","volume":"36","author":"WJ Allen","year":"2015","unstructured":"Allen, W. J. et al. DOCK 6: Impact of new features and current docking performance. J. Comput. Chem. 36, 1132\u20131156 (2015).","journal-title":"J. Comput. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57330-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57330-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57330-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T03:53:20Z","timestamp":1740974000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57330-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,2]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57330"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57330-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,2]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2112"}}